era cobiotech a new era net cofund on biotechnology...biotechnology. bundling three predecessor...
TRANSCRIPT
ERA CoBioTech – a new ERA Net Cofund on Biotechnology
Dr. Petra E. Schulte/Dr. Christian Breuer
Project Management Jülich (JUELICH)Division BioecomonyDepartment European Initiatives, International Affairs (BIO7)Forschungszentrum Jülich GmbH
Call promotion
Issues for the preparation of call launch
CoBioTech aims to provide biotechnology stakeholders with tailor-
made support regarding
information, communication, networking and
research funding
Joint funding activities
Training for scientists and funders
European BioTech Hub
Strategy
Societal challenges in the 21st century
• Increasing world population and
changes in food utilisation
patterns
• Increase of food associated
diseases
• Climate change/protection,
resource conservation/protection
• Need for a sustainable energy
production
• Transfer from a fossil to a bio-
based raw material supply
Knowledge-based Bioeconomy – Vision and Objectives
Germany pursues the vision of a
natural,
cycle-oriented,
sustainable biobased economy
that carries the promise of
global food supplies that are both
ample and healthy,
and of high quality products from
renewable resources.
meet our responsibilities for global nutrition, the protection of the climate,
efficient use of resources and the environment
What is a Bioeconomy?
• agri-tech
• (mol.) biology,
• soil, plant, animal
Production
ConversionValorisation
Consumer
• food, feed
• fiber,
• fuel
• process tech
• biotechnology
• socio-economics
• logistics
• construction
• trade
Sustainable?
Systems
analysis
History – Successors of CoBioTech
2006
€28m + €17m
€24m
€10m + €6m
€13m + €10m
€10m + €11m + €17m + €14m + €15m + €14m + €??m
2015
1 +
2
2008 2016
2012 2014189,000,000 €
From SRA – Systems Biology in Europe 2016:
Our objectives
Use synergies between current mechanisms of biotechnology research
funding in Europe
to highlight the benefits of a bio-based economy for society, and thus
to maintain and strengthen Europe’s global lead in modern
biotechnology.
Bundling three predecessor ERA-Nets in the area of biotechnology
significantly increases public funding (call volume ~ 36 Mio €),
intensifies collaboration across relevant sectors and countries, thus
advancing RD&I in industrial biotechnology
establishing systems and synthetic biology as technology
drivers in applied biotechnology, and
enhancing the potential for exploitation through active industry
involvement.
Who are we?
JUELICH DE
BMBF DE
FNR DE
MIZS SI
FCT PT
MINECO ES
SMWK DE
BBSRC UK
MINCYT AR
SPW BE
ANR FR
ADECAL NC
CSO/MOH IL
NWO NL
RCN NO
UEFISCDI RO
TUBITAK TR
VIAA LV
NCBR PL
ETAg EE
MIUR IT
CDTI ES
CTI CH
FASIE RU
NSF US
Dec. 1, 2016 – Nov. 30, 2021
22 partners
+
3 observers
The co-funded call will focus on application-oriented research in
Synthetic biology approaches to
design and construct new biological
parts, devices and systems
Systems biology approaches to
metabolic engineering and
optimisation of biological processes
Identification and use of the
metabolic potentials of genomic data
Chemical and biotechnological
approaches to transform bio-based
molecules into molecules with high
added value.
Envisaged call opening: December 1, 2016
The co-funded call: evaluation criteria
Pre-Proposals (5 pages)
Relevance to the scope of the call
Excellence
Impact
Full Proposals (30 pages)
Excellence
Impact
Implementation
Call volume CountryFunding
(up to €mio)
BMBF/JUELICH DE 9.00
FNR DE 2.00
MIZS SI 0.63
MINECO ES 1.00
SMWK DE 1.00
BBSRC UK 2.62
MINCYT AR 0.50
SPW BE 1.00
ANR FR 1.50
CSO/MOH IL 0.30
NWO NL 1.00
RCN NO 1.50
UEFISCDI RO 0.50
TUBITAK TR 1.00
VIAA LV 0.30
NCBR PL 0.70
ETAg EE 0.10
MIUR IT 0.40
CDTI ES 0.53
CTI CH 1.5
FASIE RU 1.0
Sum national contr. ~ 28 €mio
EU-Top Up * 8.7 €mio
Total Call Volume 36.7 €mio
Call Opening
(Dec 1, 2016) PP-Submission Eligibility check
Deadline for PP-Submission
(March 3, 2017)
PP-Remote-Evaluation
Inelig
ible
PP
exclu
de
d
Selection of PP for step 2
Ranked PP‘s
Step 2: Full Proposals
Mid/End May 2017
Communication to applicants
FP-Submission
Deadline for FP-Submission
(July 20, 2017)
Selection of projects
kjfdsfeoiurzoewrzvezrb
ouvlisionewrivzeoutibz
evrouewtzewotvuoiewo
uzvboiewtetuoitvVEUOI
TEWOIOFGNVEWZHO
IUPEOIURPEOTURITJ
OHOSHGPPOJXYPVO
JY
kjfdsfeoiurzoewrzvezrb
ouvlisionewrivzeoutibze
vrouewtzewotvuoiewou
zvboiewtetuoitvVEUOIT
EWOIOFGNVEWZHOI
UPEOIURPEOTURITJ
OHOSHGPPOJXYPVO
JY
kjfdsfeoiurzoewrzvezrbouvlisio
newrivzeoutibzevrouewtzewotv
uoiewouzvboiewtetuoitvVEUOI
TEWOIOFGNVEWZHOIUPEOI
URPEOTURITJOHOSHGPPO
JXYPVOJY
ST
EP
2
Project start
December 2017 - May 2018
ST
EP
1
Pre-Announcement published
Eligibility check webconf
IEP-Evaluation-Meeting
FP-Remote-Evaluation
IEP-Meeting
Ranked FP‘sCommunication to applicants
(Mid/End Oct, 2017)
National negotiations
Additional joint funding activities (without EC co-funding)
Advance RD&I in industrial biotechnology in line with the Strategic
Agenda and the outcomes of the "European Biotechnology Hub."
Depending on the availability of funds, one funding activity per year (up
to four funding activities after the co-funded call)
calls for research projects
scientific knowledge hubs
mobility awards
prizes
measures for capacity building etc..
European Biotechnology Hub - Objectives
Integrate actors from all parts of biotechnology value chains and
from all relevant scientific areas and industry sectors
policy actors,
strategic European Instruments & Initiatives
scientific and industrial actors
Provide one central umbrella to
biotechnology-relevant activities
for Europe and beyond
(e.g. EC, ERA-Nets, JTIs, PPP, KICs,
PLATFORM)
Biotech Hub Meetings
What happens?
Presenting and discussing of strategic issues, challenges, activities
Exchange of experiences regarding different and common actions
of ERA-Nets and other strategic European instruments and
initiatives in related areas
Outcome
Exchange of knowledge, „best practice“, experiences regarding
regional, national and European actions and strategies
Networks and collaborations are enlarged or strengthened
Topics for future ERA-Nets (or additional calls) or ideas for other
forms of ollaboration between policy makers and funding bodies
Recommendations to the EC
Biotech Hub Workshops
Who?
scientific and industrial actors
What happens?
Training
Ideas, demands, concepts are discussed/developed
Networks are made or strengthened
Outcome
Better understanding of other stakeholders‘ demands and ways of
working
Newly developed consortia and project ideas
New knowledge and skills, e.g. regarding European collaboration
Strategic Research and Innovation Agenda (SRIA)
maximise the long term benefit of bringing together 3 previously
separate ERA-Nets to achieve the goals of:
speeding up research and innovation in industrial
biotechnology
establishing systems biology and synthetic biology as
technology drivers while focusing on downstream industrial
applications
Shared vision, identifying areas
where synthetic biology,
systems biology, and industrial
biotechnology can be aligned to
have the most impact
Strategic Research and Innovation Agenda (SRIA)
Strategic Connections (Identification and mapping of existing relevant
national, EU, international initiatives and infrastructure).
Strategic workshops
-> The strategic agenda will describe:
areas of strategic importance between the three previous ERA-Nets,
where there is added value in advancing those areas through
transnational activities
the extent of coordination at that time which will serve as a baseline
indicator against which increases in coordination and cooperation
can be measured
a mutually agreed (and realistic) understanding of what CoBioTech
can achieve
Negative public perception
Risk of negative public perception (combined with a lack of knowledge,
e.g. „gene technology“ / „green biotechnology“)
Strategic Research and Innovation Agenda (SRIA)
Expectations and a best practice RRI framework
develop bespoke expectations and best practice RRI framework
integrate the uptake of these guidelines into funding assessment
require funded projects to report against the expectations set out in
the RRI best practice framework
Training of scientists
Communication
The co-funded call: timeline and proposals
Website: www.cobiotech.eu
Contact:
Dr. Petra E. Schulte/ Dr. Christian Breuer
Project Management Jülich (JUELICH)
Division Bioecomony
Department European Initiatives, International Affairs (BIO7)
Forschungszentrum Jülich GmbH
+(0)49 2461 61 9031
Call Office ([email protected])
Submission Website (http://www.submission-cobiotech.eu/)
